Rankings Pricing

SAPPORO CLINICAL LABORATORY INC.JP:9776

Market cap

¥8.3B

P/E ratio

12.2x

Summary Financials History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/03	2013/03	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03
Revenue	15,537	15,814	16,550	17,166	17,528	17,055	17,460	17,066	17,659	17,502	19,109	20,127	19,682	20,131
Revenue growth (%)	-
Cost of revenue	-	-	-	12,018	12,266	11,966	12,086	11,867	12,139	11,768	12,788	13,830	13,787	13,990
Gross profit	-	-	-	5,149	5,262	5,089	5,374	5,199	5,520	5,735	6,322	6,298	5,895	6,141
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating income	-	-	-	870	974	772	1,017	815	945	1,142	1,537	1,008	534	706
Operating expenses	-	-	-	4,279	4,288	4,318	4,357	4,383	4,575	4,593	4,784	5,290	5,361	5,435
Income before tax	792	759	933	897	1,000	804	1,053	813	983	1,188	1,605	1,159	514	708
Pretax margin (%)	5.1	4.8	5.6	5.2	5.7	4.7	6	4.8	5.6	6.8	8.4	5.8	2.6	3.5
Provision for income taxes	-	-	-	322	359	232	367	295	317	382	456	319	235	242
Effective tax rate (%)	-	-	-
Net income	382	441	492	574	591	514	685	523	528	791	1,024	471	460	464
Net income margin (%)
Earnings per share	104.59	115.07	124.12	150.97	169.72	147.69	197.03	152.42	154.3	231.85	306.16	170.53	114.14	148.35
Diluted EPS	104.59	115.07	124.12	150.97	169.72	147.69	197.03	152.42	154.3	231.85	306.16	170.53	114.14	148.35
Dividend payout ratio (%)
Dividend per share	11	11	11	12	11	10	11	10	10	23	23	23	23	23
EBITDA	-	-	-
EBITDA margin (%)	-	-	-

Raw aggregated data